Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Surgery Partners, Inc. on June 5, 2026. The filing details the voting outcomes for director elections, executive compensation, and the ratification of the independent auditor. As of the record date (April 8, 2026), there were 130,798,102 shares of common stock outstanding and entitled to vote.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial performance data. Information regarding revenue, profit, cash flow, margins, debt, or liquidity is not present in this document.
Material Changes
No material financial changes are reported in this filing. The document solely reflects the results of shareholder votes conducted at the Annual Meeting.
Guidance, Outlook, and Management Commentary
There is no forward-looking guidance, management commentary on operations, or discussion of risks and contingencies in this specific filing. The document confirms the re-election of the Class II directors and the approval of executive compensation and the appointment of Ernst & Young LLP as the independent auditor for fiscal year 2026.
Investor Verification Checklist
- Director Re-election: Verify the re-election of Devin O'Reilly, Brent Turner, and Laura L. Forese, M.D. as Class II directors.
- Compensation Approval: Note that the advisory vote on executive compensation was approved with 111,639,092 votes for and 2,018,777 votes against.
- Auditor Ratification: Confirm the ratification of Ernst & Young LLP for the fiscal year ending December 31, 2026.
- Voting Participation: Observe that 6,243,195 broker non-votes were recorded for the director elections.